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PROTECTIVE FACTORS AGAINST OXYGEN 
FREE RADICALS AND HYDROGEN PEROXIDE 
IN RHEUMATOID ARTHRITIS SYNOVIAL FLUID 
PIETER BIEMOND, ANTONIUS J. G. 
Oxygen free radicals are probably involved in the 
pathogenesis of rheumatoid arthritis (RA). The enzymes 
involved in protection against oxygen free radicals and 
Hz02 (superoxide dismutase, catalase, and glutathione 
peroxidase) were measured. Superoxide dismutase was 
not increased, glutathione peroxidase was slightly and 
catalase was strongly elevated in RA synovial fluid (SF) 
compared with control SF. Although these enzymes are 
present in SF, the activities are insufficient to protect 
against oxygen free radicals and HzO2. In contrast to 
transferrin, ferritin was increased in RA synovial fluid. 
Ceruloplasmin was also elevated. When rat liver micro- 
somes were used as a target for oxygen free radicals, 
serum and SF were both protective. Gel filtration 
experiments showed that the fraction pattern in which 
there was maximal protective potential against lipid 
peroxidation corresponded closely to the level of cerulo- 
plasmin. After removal of ceruloplasmin from serum or 
SF, about 70% of the protective capacity disappeared. It 
is concluded that ceruloplasmin is an important protec- 
tor against oxygen free radicals. 
Evidence is accumulating which suggests that 
oxygen free radicals such as superoxide (027 and 
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hydroxyl radical (OH'), and related oxygen species 
such as hydrogen peroxide (H202) and singlet oxygen, 
are involved in the pathogenesis of rheumatoid arthri- 
tis (RA). During phagocytosis granulocytes and mac- 
rophages produce large amounts of 02- and H202 (I).  
Oxygen free radicals destroy lipids by a process called 
lipid peroxidation. In synovial fluid (SF) from RA 
patients, degradation products of lipid peroxidation 
can be detected (2,3). In RA patients and in experi- 
mentally-induced arthritis in animals, superoxide dis- 
mutase (SOD), an enzyme destroying 02-, given sys- 
temically or  locally, induces a decrease of 
inflammation (43). In RA hyaluronic acid is depoly- 
merized, although no hyaluronidase is present in SF 
and the proteases in SF are unable to degrade hyal- 
uronic acid. Oxygen free radicals have been shown to 
cause depolymerization of hyaluronic acid (6,7). 
The deleterious effect of oxygen free radicals 
increases when iron is present. Although there is much 
debate about the exact mechanism, it is generally 
accepted that iron stimulates the formation of OH', 
possibly by the reaction: 02- + H202%OH' + 
OH- + 02. In most systems which have been investi- 
gated, this catalytic function of iron is blocked when it 
is bound to its specific binding proteins. 
The large number of phagocytosing granulo- 
cytes present in RA SF will produce a considerable 
amount of oxygen free radicals and H202. The aim of 
this study was to investigate the protection in SF 
against oxygen free radicals and H202. The following 
proteins, known to protect in vitro, were measured in 
SF: 1) SOD, which catalyses the reaction 202- + 2H+ 
+ H202  + 0,; 2) catalase and glutathione peroxidase, 
which enzymatically reduce H202 to H20; 3) ccrulo- 
plasmin, which scavenges 02- ; 4) transferrin and 
ferritin, which are iron binding proteins. 
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Figure 1. Superoxide dismutase (SOD), catalase. and glutathione 
peroxidase activities in synovial fluid (mean 2 SD) of patients with 
traumatic knee lesions (Traurn), osttoarthritis (OA), and rheumatoid 
arthritis (RA). P values for OA and KA versus Traum are shown; NS 
= not significant. 
Lipid peroxidation of rat liver microsomes in- 
duced by oxygen free radicals was used as a model. 
The  effect of oxygen free radicals in this system can be 
inhibited by serum and SF. Factors responsible for the 
inhibition were investigated. 
MATERIALS AND METHODS 
Synovial fluid and sera. SF was obtained from 7 
patients with traumatic knee lesions, 6 patients with osteoar- 
thritis (OA) of the knee, and 17 patients with classic or 
definite RA as defined by the American Rheumatism Associ- 
ation criteria (8). Sera were also obtained from the last 2 
groups. Heparin was added to the SF  samples. They were 
then centrifuged for 10 minutes at 3,000 revolutions per 
minute and the supernatants were stored at -70°C. Samples 
containing more than 15 pg hemoglobin per ml were exclud- 
ed. 
Superoxide dismutase. SOD activity was determined 
using the cytochrome C reduction inhibition method of 
McCord (9). The SOD concentration was expressed in pg 
using bovine erythrocyte SOD (Boehringer. Mannheim, 
FRG) as a standard (lot 1071 101, S.000 unitdmg). Under the 
applied conditions, SF  produced no spontaneous cyto- 
chrome C reduction. Ceruloplasmin at the concentration 
present in S F  had no significant effect on the assay. SOD 
added to SF was determined to have a recovery of 89%, so 
no significant inhibition was present in SF. 
Catalase. Catalase was measured by tracing the de- 
gradation of HzOz spectrophotometrically, according to the 
method of Aebi (10). The catalase activity in SF could be 
blocked effectively by 10 pM NaN3. Catalase added to SF 
was determined to have a recovery of 90%. 
Glutathione oeroxidase. Glutathione peroxidase con- 
Measurement of inhibition of 02- induced lipid perox- 
idation. Lipid peroxidation of rat liver microsomes isolated 
from Wistar rats (13) was performed as follows: the incuba- 
tion mixture contained (in final concentrations) 33 mM Tris- 
HCI (ph 6.8), 0.33 mM xanthine, 0.133 mg/ml dialyzed 
xanthine oxidase. 120 pM FeC13, 2 rnM ADP, and 1 mg 
protein/ml microsomes. The final volume was 3 rnl. The 
incubation was performed at 37°C and started by the addition 
of xanthine oxidase. At indicated times, samples were drawn 
and thiobarbituric acid-reacting products were measured 
(14). 
Serum or SF was applied to a 100 x 1.6 cm column of 
Sephadex G-200 and eluted at a flow rate of 6.5 ml/hour with 
50 mM Tris-HCI (pH 7.4) with 0.1 M NaCI. Fractions of the 
eluate were assayed for the capacity to inhibit lipid peroxida- 
tion of rat liver microsomes and for the concentration of 
transferrin and ceruloplasmin. 
Serum and SF  free from ceruloplasmin were pre- 
pared with a column of human ceruloplasrnin antibody 
linked to CNBr-activated Sepharose 4B. Before chrornato- 
graphy SF was pretreated with hyaluronidase to decrease the 
viscosity. The eluate was dialyzed against 2 mM sodium 
phosphate (pH 7.0) and concentrated to the original protein 
concentration. The final preparations were checked for the 
presence of ceruloplasmin. Human ceruloplasmin type X 
was from Sigma Chemical Co., St. Louis, MO. 
Statistical analysis. Significance of differences in 
concentrations was determined by Student's f-test. 
RESULTS 
Total protein. SF from patients with traumatic 
knee lesions contained 42 ? 8 mg proteinlml (mean ? 
SD), SF from patients with OA contained 49 ? 13 mg 
protein/ml, and RA SF contained 56 ? 7 mg protein/ 
ml. 
Superoxide dismutase, catalase, and glutathione 
peroxidase. SOD activities were found to  be as fol- 
lows: 1.2 5 0.6 pg/ml in SF from patients with 
traumatic knee lesions, 1.3 2 0.3 pg/rnl in OA SF, and 
1.4 ? 0.6 pg/ml in RA SF. No significant differences 
were found between these groups (Figure 1). 
The  catalase activity in SF from patients with 
traumatic knee lesions was low: 3 ? 2 units/ml. In OA 
SF it was significantly increased to  16 ? 11 unitdm1 (P 
< 0.025). and in RA SF the highest activity was found: 
42 5 25 unitdm1 (Figure 1). The  concentration in RA 
patients was significantly higher than in OA ( P  < 
0.025) and trauma patients ( P  < 0.0005). Four of the 
tent was determinei according to the method of Paglia and 
Valentine (11). One unit corresponds to 1 pmole NADPH 
oxidation per minute. The recovery of the enzyme in SF was 
100%. Ceruloplasmin and transferrin levels were estimated 
by single radial immunodiffusion (12). Ferritin content was 
determined using an enzyme immunoassay (Ferrizyme, Ab- 
bott Laboratories, Chicago, IL). 
RA patients had received aurothioglucose; they had 
very high catalase levels: 78 + 20 units/ml. The 
increase ofcatalase in OA and RA cannot be explained 
by lysis of small amounts of erythrocytes. The accept- 
ed maximal amount of hemoglobin for used SF was 15 
pg/ml. Lysis of erythrocytes resulting in 15 pg/ml 
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Figure 2. Ceruloplasmin, transferrin, and ferritin concentrations in 
synovial fluid in patients with traumatic knee lesions (Traum), 
osteoarthritis (OA), and rheumatoid arthritis (RA). P values for OA 
and RA versus Traum are shown; NS = not significant. 
Figure 3. Sephadex G-200 gel filtration of synovial fluid from a 
patlent with 
present in SF from RA patients in a concentration 15 
times higher than in the corresponding serum. 
Inhibition by serum and SF of 02- induced lipid 
peroxidation. Peroxidation of rat liver microsomes, 
induced by 02- generated by xanthine and xanthine 
oxidase in the presence of Fe3 ' ,  could be blocked by 
addition of serum and SF from both RA patients and 
controls. The inhibition was concentration-dependent, 
and about 3% serum or about 6% SF resulted in 
complete inhibition. To determine which fraction was 
responsible for this inhibition, G-200 gel filtration was 
performed. In the eluate the capacity to inhibit the 
lipid peroxidation was measured. The G-200 gel filtra- 
tion pattern of RA S F  (Figure 3) is representative of 
the SF and sera both of RA patients and controls. 
For  all samples, maximal inhibition of the lipid 
peroxidation was found between the second and third 
peaks of absorption at 280 nm. Occasionally a small 
peak at the void volume was found; this was not 
further investigated. Ceruloplasmin and transferrin 
hemoglobin in SF increased catalase activity by only 3 
units/ml. 
Glutathione peroxidase in SF from patients 
with traumatic knee lesions was 60 5 25 mU/ml, in OA 
SF it was 85 & 29 mU/ml, and in RA S F  the activity 
increased significantly to 93 2 18 mU/ml ( P  < 0.001 
versus trauma patients) (Figure 1). 
Transferrin, ferritin, and ceruloplasmin. The 
concentrations of transferrin, ferritin, and ceruloplas- 
min in SF from the 3 groups are shown in Figure 2. 
Transferrin was not significantly elevated in OA S F  or 
in RA SF. The ferritin concentration in RA SF was 
strongly increased. In RA SF the average ceruloplas- 
min concentration was twice as high as in SF from 
trauma patients, and in OA SF the amount was also 
elevated. 
The distribution of these 3 proteins between 
serum and SF from the patients is shown in Table 1. 
Both transferrin and ceruloplasmin were present in SF 
in a concentration below the serum concentration. The 
SF/serurn concentration ratio was slightly, but not 
significantly, higher in RA than in OA. Ferritin was 
arthritis. 
Table 1. 
patients with osteoarthritis and rheumatoid arthritis* 
Distribution of ceruloplasmin, transferrin, and ferritin between serum and synovial fluid of 
SF/serum 
SF Serum ratio P 
Ceruloplasmin, mglml 
NS 
0.209 2 0.059 0.423 ? 0.148 
OA (n = 6) 0.162 t 0.039 0.350 2 0.063 
RA (n = 17) 
OA (n = 6) 1.35 2 0.51 2.10 2 0.81 
RA (n  = 17) 1.49 t 0.53 2.18 2 0.77 
RA (n = 17) 2.09 2 2.77 0.15 2 0.24 14.8 2 13.6 
NS 
Transferrin, mglml 
Ferritin, pg/ml 
* Values are mean * SD. SF = synovial fluid; OA = osteoarthritis; RA = rheumatoid arthritis; NS = 
not significant. 
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Figure 4. Superoxide-induced lipid peroxidation of rat liver micro- 
somes, followed by measurement of thiobarbituric acid-reacting 
products. Complete system (0-0); final volume 3 ml. Effect of 
synovial fluid (SF) from a patient with rheumatoid arthritis 
(A-A), and the same fluid after removal of ceruloplasmin 
(A-A). 
levels were determined in the fractions obtained. The 
ceruloplasmin concentration and the inhibition of the 
lipid peroxidation in individual fractions conformed 
closely to the same pattern. From the elution pattern it 
can be concluded that under these conditions, trans- 
ferrin offers almost no protection against oxygen free 
radicals. 
To investigate the possibility that ceruloplasmin 
was able to inhibit lipid peroxidation in the described 
system, the inhibition of purified human ceruloplasmin 
was measured. Ceruloplasmin was able to inhibit 
peroxidation of rat liver microsomes in a concentra- 
tion-dependent manner. The necessary concentration 
was on the same order as found in serum and SF. 
Serum and SF from control and RA patients 
were treated with human anti-ceruloplasmin to obtain 
fluids free of ceruloplasmin. The capacity of this 
serum and SF to inhibit lipid peroxidation was com- 
pared with that of the original serum or SF. Figure 4 
shows the effect of removing ceruloplasmin on the 
inhibition of lipid peroxidation of rat liver microsomes. 
In all groups the capacity to inhibit lipid peroxidation 
was decreased by 70% with removal of ceruloplasmin. 
DISCUSSION 
There is much evidence to suggest that oxygen 
free radicals and H202 are closely involved in the 
pathogenesis of RA. Granulocytes are strongly in- 
creased in number in RA SF and produce large 
amounts of 02- and H202 during the phagocytosis of 
immune complexes and other materials (1). Oxygen 
free radicals and other secondarily formed radicals are 
possibly responsible for at least part of the joint 
destruction. Several substances are known to protect 
against oxygen free radicals in vitro, but only a small 
number of investigations have been performed on 
detecting these protectors in RA. 
Conflicting data are presented in the literature 
about the concentration of superoxide dismutase in 
RA SF. Blake et a1 found no SOD at all in RA SF (15). 
Igari et a1 (16), however, showed a low concentration 
in OA SF but a 4 times higher level in RA SF. The 
concentration of SOD in granulocytes was decreased 
by 40% in juvenile RA patients (17). 
Banford et a1 (18) measured SOD in erythro- 
cytes in patients with RA. The SOD concentration of 
hemolysate was decreased in RA; however, a decrease 
in hemoglobin concentation was also found. The low 
concentration of SOD in hemolysate found in that 
study can be explained by the anemia commonly found 
in RA. 
In the present study a low SOD concentration 
in SF from patients with traumatic knee lesions and 
with OA was found, in agreement with the results 
reported by Igari et al for OA. In contrast with Igari's 
findings, the SOD concentration in RA was not elevat- 
ed in our study. It is very doubtful that this low SOD 
concentration can protect against oxygen free radicals. 
In various cell types and tissues, SOD activity is 18- 
440 times higher, and in in vitro systems higher 
concentrations are needed to protect against oxygen 
free radicals. 
Catalase and glutathione peroxidase are capa- 
ble of detoxifying Hz02. Blake et a1 (15) found low 
concentrations of catalase in RA SF, but no reference 
group was investigated. We estimated almost no cata- 
lase activity in SF from trauma patients. In OA SF the 
concentration was elevated, and in RA SF a further 
increase occurred. Within the RA group 4 patients 
who received aurothioglucose had very high catalase 
levels. Although catalase is significantly increased in 
RA, we agree with Blake et al that the concentration is 
too low to expect considerable protection against 
H202 in SF. 
Glutathione peroxidase was elevated in RA SF 
compared with SF from trauma patients. This increase 
was nearly as great as the increase of total protein 
found in RA SF. No increase in transferrin concentra- 
tion was found in RA SF. The concentration is, 
however, high enough to bind about 4 times the 
amount of iron known to be present in SF (19). In most 
systems transferrin-bound iron is not able to catalyze 
the formation of OH'. Thus, before iron can have a 
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deleterious effect, it must be separated from transfer- 
rin. Another possibility is that iron is bound very 
tightly in a small complex which prevents binding to 
transferrin. 
Ferritin was strongly increased in RA SF com- 
pared with both OA and traumatic SF. This is in 
agreement with the results of Blake et al (20). The 
ferritin concentration in RA SF was on the average 15 
times higher than in the corresponding serum. It is 
unlikely that ferritin in RA S F  is derived from serum, 
which is the case for most other serum proteins, such 
as ceruloplasmin and transferrin. The concentration of 
these proteins in SF is less than the corresponding 
serum value. We favor the hypothesis that ferritin is 
synthesized by synovial membrane cells and enters SF 
by secretion or by release from dying cells. The high 
production of ferritin by synovial cells, as shown by 
Muirden et al (21), is a protective reaction to the 
continuous iron release in SF, due to blood loss and 
the resulting breakdown of hemoglobin. Ferritin and 
transferrin can both play a dual role: 1) protection 
against oxygen free radicals by binding free iron, or 2) 
stimulation of OH’ production by release of free iron 
from the binding protein. In this context the percent- 
age of iron saturation could be very important. 
Ceruloplasmin has been shown to possess 02- 
scavenging activity (22). The present investigations 
confirm that this acute phase reactant is elevated in 
RA SF (23,24). 
There are several potential protectors against 
oxygen free radicals in SF, but the relative importance 
of these proteins is unknown. Stocks et al (25) have 
investigated inhibition of lipid peroxidation by serum. 
They used brain homogenate as a lipid peroxidating 
system, which could be blocked by small amounts of 
serum. They concluded that the protection by serum 
against oxygen free radical induced lipid peroxidation 
was based on the presence of transferrin and another 
protein, most likely ceruloplasmin. In the present 
study O2 ~ induced lipid peroxidation of rat liver 
microsomes was used. Serum and SF from both con- 
trols and RA patients blocked this process. 
Gel filtration of serum or SF from both groups 
showed a peak at which lipid peroxidation was inhibit- 
ed. The position of this peak did not correspond with 
transferrin levels, but did correspond with ceruloplas- 
min levels. The postulated role of ceruloplasmin was 
strengthened by the fact that purified human cerulo- 
plasmin was able to inhibit lipid peroxidation in the 
system used on the same order of concentrations as 
were present in serum or SF. Furthermore, the inhibi- 
tion of lipid peroxidation by ceruloplasmin-free serum 
or SF was diminished by about 70% compared with the 
corresponding complete serum or SF. 
Ceruloplasmin is definitely shown to be an 
important protector against oxygen free radicals in 
serum and synovial fluid both in controls and rheuma- 
toid arthritis patients. Our system is not appropriate 
for detecting a possible inhibitory effect of transferrin 
or other iron binding proteins, since rather high con- 
centrations of iron were added. 
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